Neok Bio, Inc.
Clinical trials sponsored by Neok Bio, Inc., explained in plain language.
-
New drug aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests an experimental drug called NEOK002 in people with advanced solid tumors that have spread and cannot be removed by surgery. The drug is designed to target two proteins on cancer cells to deliver a toxic payload. The study has two parts: first, finding the safest …
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New drug NEOK001 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called NEOK001 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target two proteins on cancer cells to deliver a toxic payload. The study will first find the safest dose and t…
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC